• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从未吸烟的肺癌患者:不同的人口统计学特征,相似的生存。

Never smokers with resected lung cancer: different demographics, similar survival.

机构信息

Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Weill Cornell Medicine, Cornell University, New York-Presbyterian Hospital, New York, NY, USA.

出版信息

Eur J Cardiothorac Surg. 2018 Apr 1;53(4):842-848. doi: 10.1093/ejcts/ezx390.

DOI:10.1093/ejcts/ezx390
PMID:29182735
Abstract

OBJECTIVES

We sought to examine changes over time in the proportion of never smokers among surgical lung cancer patients and to determine whether smoking history affected survival.

METHODS

We performed a retrospective review of a prospective database. Among never smokers and smokers, demographic and pathological data were compared. Disease-free survival (DFS) and cancer-specific survival (CSS) were analysed. Propensity matching was performed for further comparison of survival in a matched cohort.

RESULTS

Among 3232 patients, we identified 718 never smokers (22%), 993 smokers with <30 pack history (31%) and 1521 smokers with ≥30 pack history (47%). The proportion of never smokers increased over time, comprising 26.6% of the cohort after 2007 compared with 16.1% prior thereto (P ≤ 0.001). Never smokers were younger, more likely to be women and Asian, more frequently had adenocarcinoma and lower lobe tumours and were more likely to have pStage I disease. In pStage-matched cohorts, there were no differences in DFS or CSS. Similarly, in propensity-matched groups (498 patients each), there was no difference in 5-year DFS (66% vs 67%, P = 0.661) or in CSS (84% vs 81%, P = 0.350). On univariate analysis of the matched cohort, never smoking status had no effect on DFS (hazard ratio 1.05, P = 0.661) or CSS (hazard ratio 1.16, P = 0.350).

CONCLUSIONS

The proportion of never smokers undergoing resections for lung cancer is increasing. Never smokers have distinct demographic patterns and tend to be younger women with adenocarcinoma. Despite these differences, stage and propensity-matched never smokers have the same survival as smokers and remain at equal risk for recurrence and death.

摘要

目的

我们旨在研究手术治疗肺癌患者中从不吸烟者的比例随时间的变化,并确定吸烟史是否影响生存。

方法

我们对前瞻性数据库进行了回顾性研究。在从不吸烟者和吸烟者中,比较了人口统计学和病理学数据。分析了无病生存期(DFS)和癌症特异性生存期(CSS)。进行倾向匹配以进一步比较匹配队列中的生存情况。

结果

在 3232 名患者中,我们确定了 718 名从不吸烟者(22%)、993 名吸烟史<30 包(31%)和 1521 名吸烟史≥30 包(47%)的患者。从不吸烟者的比例随时间增加,与 2007 年之前相比,2007 年后队列中从不吸烟者的比例从 16.1%增加到 26.6%(P≤0.001)。从不吸烟者更年轻,更可能是女性和亚洲人,更常患有腺癌和下叶肿瘤,更可能患有 p 期 I 期疾病。在 p 期匹配队列中,DFS 或 CSS 无差异。同样,在倾向匹配组(每组 498 名患者)中,5 年 DFS(66%比 67%,P=0.661)或 CSS(84%比 81%,P=0.350)无差异。在匹配队列的单因素分析中,从不吸烟状态对 DFS(风险比 1.05,P=0.661)或 CSS(风险比 1.16,P=0.350)没有影响。

结论

接受肺癌切除术的从不吸烟者的比例正在增加。从不吸烟者具有明显的人口统计学模式,往往是年轻的女性,患有腺癌。尽管存在这些差异,但分期和倾向匹配的从不吸烟者的生存情况与吸烟者相同,复发和死亡的风险相同。

相似文献

1
Never smokers with resected lung cancer: different demographics, similar survival.从未吸烟的肺癌患者:不同的人口统计学特征,相似的生存。
Eur J Cardiothorac Surg. 2018 Apr 1;53(4):842-848. doi: 10.1093/ejcts/ezx390.
2
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.患非小细胞肺癌的吸烟者与从不吸烟者在流行病学、组织学和生存率方面的差异。
Chest. 2007 Jul;132(1):185-92. doi: 10.1378/chest.07-0442. Epub 2007 Jun 15.
3
Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?从不吸烟者和曾吸烟者的非小细胞肺癌:是同一种疾病吗?
J Thorac Cardiovasc Surg. 2021 Jun;161(6):1903-1917.e9. doi: 10.1016/j.jtcvs.2020.03.175. Epub 2020 Jun 18.
4
Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.比较肺功能诊断的慢性阻塞性肺疾病(COPD)和非 COPD 从不吸烟的 I-IV 期非小细胞肺癌患者的临床特征和总生存期。
Int J Chron Obstruct Pulmon Dis. 2019 May 1;14:929-938. doi: 10.2147/COPD.S190244. eCollection 2019.
5
Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.吸烟对携带激活型表皮生长因子受体(EGFR)突变的肺腺癌患者表皮生长因子受体(EGFR)-酪氨酸激酶抑制剂治疗反应的影响。
Lung Cancer. 2014 May;84(2):196-202. doi: 10.1016/j.lungcan.2014.01.022. Epub 2014 Feb 3.
6
Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.癌症护理结果研究与监测(CanCORS)中肺癌非吸烟者的生存率
Ann Am Thorac Soc. 2016 Jan;13(1):58-66. doi: 10.1513/AnnalsATS.201504-241OC.
7
Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.肺原发性腺癌患者中从不吸烟者与当前吸烟者相比生存率提高。
Chest. 2004 Aug;126(2):347-51. doi: 10.1378/chest.126.2.347.
8
Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity.非吸烟肺癌患者:一种独特疾病实体的流行病学证据
J Clin Oncol. 2006 May 20;24(15):2245-51. doi: 10.1200/JCO.2005.04.8033.
9
Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.吸烟史预示着更高的第二原发性肺癌风险:综合分析。
Cancer. 2015 Feb 15;121(4):598-604. doi: 10.1002/cncr.29095. Epub 2014 Oct 3.
10
Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).非小细胞肺癌(NSCLC)终身不吸烟者的临床表现及特定分期结局。
J Thorac Oncol. 2007 Sep;2(9):827-30. doi: 10.1097/JTO.0b013e318145af79.

引用本文的文献

1
Impact of Environmental Exposures on Lung Cancer in Patients Who Never Smoked.环境暴露对从不吸烟的肺癌患者的影响。
World J Surg. 2023 Oct;47(10):2578-2586. doi: 10.1007/s00268-023-07085-3. Epub 2023 Jul 4.
2
Identification of a novel survival predictor, CSF2RB, for female lung cancer in never smokers (LCNS) by a bioinformatics analysis.生物信息学分析鉴定出一个新的生存预测因子 CSF2RB,用于从不吸烟者(LCNS)女性肺癌。
Medicine (Baltimore). 2023 Jun 9;102(23):e34019. doi: 10.1097/MD.0000000000034019.
3
Smoking status and the association between patient-level factors and survival among lung cancer patients.
吸烟状况与肺癌患者个体因素与生存的相关性。
J Natl Cancer Inst. 2023 Aug 8;115(8):937-948. doi: 10.1093/jnci/djad098.
4
Disparities in Lung Cancer: A Targeted Literature Review Examining Lung Cancer Screening, Diagnosis, Treatment, and Survival Outcomes in the United States.肺癌的差异:一项针对美国肺癌筛查、诊断、治疗和生存结果的目标文献综述。
J Racial Ethn Health Disparities. 2024 Jun;11(3):1489-1500. doi: 10.1007/s40615-023-01625-2. Epub 2023 May 19.
5
The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screening.大多数可切除的偶然发现的肺癌患者不符合肺癌筛查的条件。
JTCVS Open. 2022 Dec 13;13:379-388. doi: 10.1016/j.xjon.2022.11.021. eCollection 2023 Mar.
6
Prognostic significance of PD-L1 expression and CD8 TILs density for disease-free survival in surgically resected lung squamous cell carcinoma: a retrospective study.PD-L1表达和CD8肿瘤浸润淋巴细胞密度对手术切除的肺鳞状细胞癌无病生存的预后意义:一项回顾性研究
J Thorac Dis. 2022 Jun;14(6):2224-2234. doi: 10.21037/jtd-22-630.
7
Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer.长链非编码 RNA Opa 相互作用蛋白 5-反义 RNA 1 结合 microRNA-34a 上调非小细胞肺癌中的致癌性 PD-L1。
Bioengineered. 2022 Apr;13(4):9264-9273. doi: 10.1080/21655979.2022.2036904.
8
SPINK5 is a Tumor-Suppressor Gene Involved in the Progression of Nonsmall Cell Lung Carcinoma through Negatively Regulating PSIP1.丝氨酸蛋白酶抑制剂 Kazal 型 5(SPINK5)是一种抑癌基因,通过负向调控 PSIP1 参与非小细胞肺癌的进展。
J Healthc Eng. 2022 Mar 25;2022:2209979. doi: 10.1155/2022/2209979. eCollection 2022.
9
Effects of Ethnicity on Outcomes of Patients With Mutation-Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection.种族对接受表皮生长因子受体酪氨酸激酶抑制剂和手术切除治疗的突变阳性非小细胞肺癌患者预后的影响。
JTO Clin Res Rep. 2021 Dec 4;3(2):100259. doi: 10.1016/j.jtocrr.2021.100259. eCollection 2022 Feb.
10
Dual Nature of Relationship between Mycobacteria and Cancer.分枝杆菌与癌症的关系具有双重性。
Int J Mol Sci. 2021 Aug 3;22(15):8332. doi: 10.3390/ijms22158332.